Lumosa Therapeutics Co., Ltd. (6535.TWO)
TWD 191.0
(-1.29%)
TWD 191.0
(-1.29%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 12.61 Million TWD | 168.87% |
| 2022 | 4.69 Million TWD | -59.17% |
| 2021 | 11.48 Million TWD | -32.24% |
| 2020 | 16.95 Million TWD | 44.73% |
| 2019 | 11.71 Million TWD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 10.54 Million TWD | -8.87% |
| 2024 Q1 | 11.57 Million TWD | -8.25% |
| 2023 Q4 | 12.61 Million TWD | 769.06% |
| 2023 Q1 | 3.61 Million TWD | -22.9% |
| 2023 FY | 12.61 Million TWD | 168.87% |
| 2023 Q3 | 1.45 Million TWD | -42.78% |
| 2023 Q2 | 2.53 Million TWD | -29.87% |
| 2022 Q3 | 5.75 Million TWD | 0.0% |
| 2022 Q4 | 4.69 Million TWD | -18.56% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | 113.44 Million TWD | 88.885% |
| Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 95.554% |
| Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -1349.425% |
| Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 95.306% |
| NaviFUS Corp. | 32.69 Million TWD | 61.429% |
| G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -132.186% |
| TaiRx, Inc. | 12.28 Million TWD | -2.637% |
| Sinew Pharma Inc. | 6.46 Million TWD | -95.08% |
| Lin BioScience, Inc. | 42.87 Million TWD | 70.588% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -976.857% |
| Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -811.786% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 96.869% |
| AP Biosciences Inc | 82.07 Million TWD | 84.637% |
| Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 92.757% |
| RBC Bioscience Corporation | 487.36 Million TWD | 97.413% |
| Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 98.15% |
| EirGenix Inc. | 465.16 Million TWD | 97.289% |
| Enimmune corporation | 45.73 Million TWD | 72.428% |
| Lukas Biomedical Inc. | 82.55 Million TWD | 84.725% |
| BRIM Biotechnology, Inc. | 3.59 Million TWD | -251.058% |
| 3D Global Biotech Inc. | 10.37 Million TWD | -21.495% |
| TaiMed Biologics Inc. | 750.85 Million TWD | 98.321% |
| Mycenax Biotech Inc. | 726.27 Million TWD | 98.264% |
| TCI GENE Inc. | 6.79 Million TWD | -85.578% |
| SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -496.5% |
| Oneness Biotech Co., Ltd. | 397.95 Million TWD | 96.831% |
| Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -189.619% |
| Feng Chi Biotech Corp. | 10.79 Million TWD | -16.781% |
| NeoCore Technology Co., Ltd. | 96.89 Million TWD | 86.985% |
| TWi Biotechnology, Inc. | 7.97 Million TWD | -58.198% |
| Neith Corporation | 3.54 Million TWD | -256.114% |
| Sunny Pharmtech Inc. | 391.42 Million TWD | 96.778% |
| VBI | - TWD | -Infinity% |
| Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | -113.801% |
| GeneReach Biotechnology Corp. | 257.03 Million TWD | 95.094% |
| Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -2243.866% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | 53.505% |
| MegaPro Biomedical Co., Ltd | 8.31 Million TWD | -51.599% |
| Visgeneer Inc. | 158.6 Million TWD | 92.049% |
| Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 93.571% |
| BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 78.336% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 96.976% |
| Sagittarius Life Science Corp | 13.32 Million TWD | 5.352% |
| BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | 3.682% |
| GlycoNex Incorporation | 900 Thousand TWD | -1301.111% |
| Medigen Biotechnology Corp. | 2.91 Billion TWD | 99.567% |
| Pharmosa Biopharm Inc. | 144.36 Million TWD | 91.265% |
| PharmaEngine, Inc. | 14.8 Million TWD | 14.849% |
| Intech Biopharm Corporation | 1.43 Billion TWD | 99.121% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 96.061% |
| BiOptic Inc. | 93.19 Million TWD | 86.47% |
| TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 83.116% |
| Senhwa Biosciences, Inc. | 9.6 Million TWD | -31.34% |
| NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | -18.049% |
| OBI Pharma, Inc. | 501.05 Million TWD | 97.483% |
| Savior Lifetec Corporation | 270.37 Million TWD | 95.336% |
| Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | 12.278% |
| Level Biotechnology Inc. | 13.5 Million TWD | 6.606% |
| Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 99.361% |
| Meribank Biotech Co., Ltd | 34.03 Million TWD | 62.954% |
| Acepodia, Inc. | 273.81 Million TWD | 95.395% |
| Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | 38.362% |